A recent scientific study presents a new perspective that could reshape the understanding of multiple sclerosis, suggesting that the digestive system—particularly the gut—may play a central role in the early development of the disease through its influence on the immune system.
Multiple sclerosis is an autoimmune condition in which the immune system attacks the nervous system, but the initial trigger behind this response has long remained unclear. The study indicates that the process may begin in the gut, where the immune system interacts with bacteria and microorganisms.
Within the gut, a specific type of immune cell known as Th17 cells becomes activated. These cells are associated with inflammation. The process begins when the gut encounters microbes, leading to the activation and transformation of these cells into highly inflammatory agents, which then travel through the bloodstream to the nervous system, where they may begin attacking the brain and spinal cord.
The gut functions not only as a digestive organ but also as a major regulator of the immune system, capable of “training” immune cells before they circulate throughout the body. Some gut cells can present foreign substances to the immune system, triggering strong immune responses that may later misdirect against the body’s own tissues.
Gut microbiota also plays a significant role in this mechanism. Changes in the balance of gut bacteria can influence immune behavior, potentially increasing inflammation, triggering abnormal immune responses, and worsening disease progression.
In some cases, the immune system may fail to distinguish between harmful microbes and the body’s own tissues, leading to unintended attacks on the nervous system.
This discovery opens new possibilities for treatment strategies that target the gut rather than focusing solely on the brain and spinal cord. Approaches such as modifying gut bacteria, reducing inflammation from within the digestive system, and preventing activation of harmful immune cells may become important therapeutic directions.
Researchers believe that the gut–brain axis could be key to understanding not only multiple sclerosis but also other neurological diseases, potentially shifting future treatments toward addressing the root causes within the body.
For more details and latest news follow Misr Connect
